Pivot Park campus is a proven driver of innovation and entrepreneurship, with more than 1.000 people employed at more than 60 companies across the community. This spirit of innovation includes supporting life science education and building links with universities, research institutes and other science and technology campuses in the Netherlands and Europe.
We do this by understanding that start-ups and growing companies drive the development of innovative medicines. So we help these visionary entrepreneurs to define the factors that will be critical to their success. Then we ensure they have all the resources that are critical to their business. Things like customised lab and office facilities, support services, pathways to finance, gateways to knowledge and access to outstanding scientific and entrepreneurial expertise. And we accelerate the development of pharmaceutical innovation by connecting new and growing companies to the benefit of the organisations and their people who work here.
The result is the foremost campus for biopharmaceutical innovation and discovery in Europe today. A dynamic and uniquely pharma-based knowledge community that is primed to excel, accelerate and grow.
Pivot Park is part of an ecosystem of leading companies and knowledge institutes that focus on innovations in drug development. Through these connections, the park community helps ambitious entrepreneurs ensure they have all the resources they need to accelerate their growth.
Our tenants include on-site advisors who can assist with funding, mergers and partnerships – the financial expertise that start-ups and scale-ups often need. Young businesses also frequently require highly specialised equipment and know-how, but often lack the resources to build their own. So, it’s good to know that several companies at Pivot Park offer ready-to-use facilities and expert guidance to the community. These include two GMP-qualified pilot plants (gram-to-kilogram and fill-and-finish), analytical support including NMR, LC-MS and cleanrooms and a well-equipped Open Access Laboratory. Pivot Park is also the only place in Europe to offer an ultra-high-throughput screening centre to accelerate drug discoveries. Further, the community benefits from a large pharma ecosystem that consists of Pivot Park and its neighbours Aspen, MSD and Organon.
In 2022-23, Pivot Park, Organon, Aspen, MSD and the city of Oss will celebrate 100 years of pharma R&D and production in Oss. Find out more here >
The campus is also closely aligned with the city of Oss, which has defined life sciences, agri-food and logistics as fundamental economic building blocks. The city’s strategy therefore complements the needs of our pharma R&D offering, making it an ideal location for companies looking to develop, scale up and commercialise products and processes. Pivot Park is also part of a wider ecosystem that includes the adjoining Health Valley life science and innovation network.
The result is business-focused support from an exceptional network of industry, research, academic and professional training organisations, located in a city and region that welcomes and supports innovation and innovative companies.
Pivot Park was created next to the Organon/ MSD site in Oss in 2012. Since then, it has grown exponentially. In 2020, Pivot Park revealed ambitious plans for new buildings and a further scaling up of its offering, cementing its position as Europe’s foremost pharmaceutical campus.
Oss’s development into a pharmaceutical hotspot began when Dr Saal van Zwanenberg founded Organon as a separate part of his meat processing factory.
Zwanenberg wanted to find a use for the offal from his factories, but while there was a suspicion that animal organs contained medically useful substances, no one knew how to isolate them.
This changed in 1921 when two Canadian researchers discovered how to extract insulin
from the pancreas. Learning of this, Saal van Zwanenberg founded Organon in 1923. Working with chemists Ernst Laqueur and Jacques van Oss, the three found a way to extract insulin on an industrial scale from the pancreas of slaughtered pigs. The first Organon product was created. From there, Organon went on to develop a broad range of groundbreaking discoveries, such as insulin and the anti-conception pill.
One hundred years on and Oss, the cradle of the Dutch pharmaceutical sector, is still a thriving location. Pivot Park has everything required by the next generation of pharmaceutical innovators. An environment filled with like-minded people encourages entrepreneurship and there is nowhere else in the Netherlands with so much pharmaceutical knowledge and expertise within one square kilometre.
The basic concept is to find practical ways in which Pivot Park can contribute to making a positive social impact while achieving financial growth. The biggest and most obvious area in which we can do this is housing and the services that go with operating a leading life science campus – energy, waste, mobility options, the social aspects, employability and so on. In doing so, we take the entire lifecycle and chain into account so that we meet the needs of the present without compromising the ability of future generations to meet their needs.
You can read more about our record and ambitions in the sustainability policy.
The Pivot Park network includes life science, health, innovation, business development and other key knowledge partners who directly and indirectly support the ambitions of the park and our tenants. As a Pivot Park tenant, we can help you with useful contacts on a wide range of topics. Our partners also regularly share their knowledge through events and network activities. Below is an overview of some of the partners of Pivot Park. For more specific information about our partners’ services and specialisms, contact firstname.lastname@example.org.
The opportunity to create in the
Netherland a kind of Boston by the North Sea
Brabant Development Association
The power of working together on successful drug discovery
To download our sustainability report we would like to receive your e-mail.
To print our sustainability report we would like to receive your e-mail.
10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.
We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.
The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.
Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.
This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.
We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.
Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.